A detailed history of Black Barn Capital Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Black Barn Capital Partners LP holds 4,000,000 shares of ROIV stock, worth $50.1 Million. This represents 6.07% of its overall portfolio holdings.

Number of Shares
4,000,000
Previous 3,100,000 29.03%
Holding current value
$50.1 Million
Previous $32.8 Billion 40.87%
% of portfolio
6.07%
Previous 2.91%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.17 - $12.5 $9.15 Million - $11.3 Million
900,000 Added 29.03%
4,000,000 $46.2 Billion
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $12.4 Million - $14.1 Million
1,199,406 Added 63.11%
3,100,000 $32.8 Billion
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $3.46 Million - $4.14 Million
350,594 Added 22.62%
1,900,594 $20 Billion
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $13 Million - $17.9 Million
1,550,000 New
1,550,000 $17.4 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.83B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Black Barn Capital Partners LP Portfolio

Follow Black Barn Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Barn Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Black Barn Capital Partners LP with notifications on news.